Skip to Content

Notice

National Cancer Institute; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting of the National Cancer Advisory Board.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Advisory Board, Ad Hoc Subcommittee on Communications.

Dates: September 10-11, 2001.

Open: 7 p.m.-8:30 p.m.

Agenda: To discuss activities related to the Ad Hoc Subcommittee on Communications.

Place: Bethesda Hyatt Regency Hotel, One Bethesda Metro Center, Bethesda, MD 20814, (301) 657-1234.

Contact Person: Dr. Susan Sieber, Executive Secretary, Ad Hoc Subcommittee on Communications, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 31, Room 11A48, Bethesda, MD 20892, (301) 496-5946.

Name of Committee: National Cancer Advisory Board, Subcommittee on Cancer Centers.

Date: September 10, 2001.

Open: 7 p.m.-8:30 p.m.

Agenda: To discuss activities related to the Subcommittee on Cancer Centers.

Place: Bethesda Hyatt Regency Hotel, One Bethesda Metro Center, Bethesda, MD 20814, (301) 657-1234.

Contact Person: Dr. Brian Kimes, Executive Secretary, Subcommittee on Cancer Centers, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Suite 700, Bethesda, MD 20892, (301) 496-8537.

Name of Committee: National Cancer Advisory Board.

Date: September 11, 2001.

Open: 8:30 a.m. to 12:15 p.m.

Agenda: Program reports and presentations; Business of the Board.

Place: National Cancer Institute, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.

Name of Committee: National Cancer Advisory Board, Subcommittee on Clinical Investigations.

Open: 12:25 p.m. to 1:30 p.m.

Agenda: To discuss activities related to the Subcommittee on Clinical Investigations.

Place: National Cancer Institute, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.

Contact Person: Dr. Ellen Feigal, Executive Secretary, Subcommittee on Clinical Investigations, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 31, Room 3A44, Bethesda, MD 20892, (301) 496-6711.

Name of Committee: National Cancer Advisory Board.

Open: September 11, 2001, 1:30 p.m. to 3:50 p.m.

Agenda: Program reports and presentations; Business of the Board.

Place: National Cancer Institute, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.

Name of Committee: National Cancer Advisory Board.

Closed: September 11, 2001, 4:10 p.m. to Adjournment.

Agenda: Review of grant applications; Discussion of confidential personnel issues.

Place: National Cancer Institute, 9000 Rockville Pike, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.

Contact Person: Dr. Marvin R. Kalt, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327, (301) 496-5147.

This meeting is being published less than 15 days prior to the meeting due to scheduling conflicts. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

Information is also available on the Institute's/Center's home page: deainfo.nci.nih.gov/advisory/ncab.htm, where an agenda and any additional information for the meeting will be posted when available.

Start Signature

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS).

Dated: August 17, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 01-21519 Filed 8-24-01; 8:45 am]

BILLING CODE 4140-01-M